A detailed history of Cutter Capital Management, LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cutter Capital Management, LP holds 97,300 shares of IONS stock, worth $3.31 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
97,300
Previous 160,166 39.25%
Holding current value
$3.31 Million
Previous $7.63 Billion 48.94%
% of portfolio
1.15%
Previous 2.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $2.52 Million - $3.26 Million
-62,866 Reduced 39.25%
97,300 $3.9 Billion
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $4.71 Million - $6.16 Million
-129,200 Reduced 44.65%
160,166 $7.63 Billion
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $12.2 Million - $15.5 Million
289,366 New
289,366 $12.5 Billion

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Cutter Capital Management, LP Portfolio

Follow Cutter Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutter Capital Management, LP with notifications on news.